139 related articles for article (PubMed ID: 21721453)
1. Incidence and risk factors of bone marrow involvement by non-Hodgkin lymphoma.
Kittivorapart J; Chinthammitr Y
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S239-45. PubMed ID: 21721453
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological studies on bone marrow involvement of non-Hodgkin's lymphoma].
Chen H; Qian L; Shen J
Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):513-5. PubMed ID: 11235578
[TBL] [Abstract][Full Text] [Related]
3. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
[TBL] [Abstract][Full Text] [Related]
4. A review of histology of bone marrow trephine in malignant lymphomas.
Durosinmi MA; Mabayoje VO; Akinola NO
Niger J Med; 2003; 12(4):198-201. PubMed ID: 14768193
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow and peripheral blood changes in non-Hodgkin's lymphoma.
Lim EJ; Peh SC
Singapore Med J; 2000 Jun; 41(6):279-85. PubMed ID: 11109344
[TBL] [Abstract][Full Text] [Related]
6. [The value of multiparameter flow cytometry in diagnosis of lymphocytic leukemia and bone marrow involvement of non-Hodgkin's lymphoma].
Sun XF; He LR; Feng HL; Yan SL; Xia ZJ; Chen XQ
Ai Zheng; 2003 Nov; 22(11):1232-6. PubMed ID: 14613660
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome of low-grade NHL patients with bone marrow involvement.
Gronich N; Radnay J; Shapiro H; Manor Y; Lahav M; Lishner M
Eur J Clin Invest; 2007 Apr; 37(4):305-9. PubMed ID: 17373966
[TBL] [Abstract][Full Text] [Related]
8. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
[TBL] [Abstract][Full Text] [Related]
9. [Advances of bone marrow biopsy pathology in diagnosing lymphoma bone marrow involvement].
Liu EB; Chen HS
Ai Zheng; 2005 Nov; 24(11):1416-20. PubMed ID: 16552975
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology.
Duggan PR; Easton D; Luider J; Auer IA
Cancer; 2000 Feb; 88(4):894-9. PubMed ID: 10679660
[TBL] [Abstract][Full Text] [Related]
11. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study.
Kumar S; Rau AR; Naik R; Kini H; Mathai AM; Pai MR; Khadilkar UN
Indian J Pathol Microbiol; 2009; 52(3):332-8. PubMed ID: 19679954
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
14. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
[TBL] [Abstract][Full Text] [Related]
15. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
[TBL] [Abstract][Full Text] [Related]
16. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and risk of malignant lymphoma in Scandinavian men and women.
Chang ET; Hjalgrim H; Smedby KE; Akerman M; Tani E; Johnsen HE; Glimelius B; Adami HO; Melbye M
J Natl Cancer Inst; 2005 Feb; 97(3):210-8. PubMed ID: 15687364
[TBL] [Abstract][Full Text] [Related]
18. An immunocytochemical study of lymphocyte and macrophage populations in the bone marrow of patients with non-Hodgkin's lymphoma.
Nash JR; Smith SR; Mackie MJ
J Pathol; 1988 Feb; 154(2):141-9. PubMed ID: 3280765
[TBL] [Abstract][Full Text] [Related]
19. [Bone marrow biopsy in non-Hodgkin's lymphoma: experience with 259 samples].
Hernández Nieto L; Hernández García MT; González Brito G; Brito Barroso ML; Marsa Vila L; Chavez MI
Sangre (Barc); 1989 Aug; 34(4):271-7. PubMed ID: 2772780
[TBL] [Abstract][Full Text] [Related]
20. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
